| Betterchem |

|
|
|
| FDA approval activities
for this prescription drug:
Panretin (alitretinoin) Gel, 0.1%, Ligand NDA 20-886 2/2/99 2/5/99 2/5/99 6/16/99 Panretin Indication: Treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma. |
© 2009 Betterchem.com
|